HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$16.28
Day range
$14.65 - $15.63
Year range
$10.93 - $24.18
Market cap
1.00B USD
Avg Volume
1.17M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 72.00K | -26.53% |
Operating expense | 15.02M | -31.18% |
Net income | -48.54M | 28.77% |
Net profit margin | -67.42K | 3.05% |
Earnings per share | -0.79 | 50.93% |
EBITDA | -55.75M | 22.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 613.19M | 64.02% |
Total assets | 630.38M | 63.04% |
Total liabilities | 47.85M | 32.58% |
Total equity | 582.53M | — |
Shares outstanding | 63.82M | — |
Price to book | 2.71 | — |
Return on assets | -24.94% | — |
Return on capital | -26.16% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -48.54M | 28.77% |
Cash from operations | -45.22M | 27.03% |
Cash from investing | -143.04M | -975.93% |
Cash from financing | 177.08M | 2,058.48% |
Net change in cash | -11.19M | 83.32% |
Free cash flow | -27.39M | 24.13% |
About
Founded
2010
Headquarters
Website
Employees
96